BALTIMORE, Sept. 29 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Inc. (NASDAQ:GLFD) today announced that its stockholders approved the...
MGI PHARMA, INC. (Nasdaq:MOGN), an oncology and acute care focused biopharmaceutical company, and Guilford Pharmaceuticals Inc. (Nasdaq:GLFD), a...
BALTIMORE, Aug. 8 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Inc. (NASDAQ:GLFD) today reported financial results for the quarter ended...
BALTIMORE, Aug. 2 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Inc. (NASDAQ:GLFD) will host a conference call and live audio webcast to...
Guilford Pharmaceuticals Implements Strategic Reorganization to Align Resources With Corporate Strategy BALTIMORE, May 24 /PRNewswire-FirstCall/...
Guilford Pharmaceuticals Presents New NAALADase Inhibitor Data in Chemotherapy-Induced Neuropathy at ASCO BALTIMORE, May 18...
Guilford Pharmaceuticals Announces Promising Results at ASCO in Study of Newly Diagnosed High Grade Malignant Glioma Study Suggests Safety of...
AGGRASTAT(R) Injection Strategy Trial Data Published in JAMA BALTIMORE, May 11 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals...
Guilford Pharmaceuticals Reports 2005 First Quarter Results BALTIMORE, May 9 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals...
Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005 BALTIMORE, May 2 /PRNewswire-FirstCall/...
Guilford Pharmaceuticals Restarts AQUAVAN(R) Clinical Development Program BALTIMORE, April 21 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals...
Guilford Pharmaceuticals to Host Webcast Outlining New Corporate Strategy BALTIMORE, April 5 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads